Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Zhongzhu Healthcare Holding Co's Days Payable or its related term are showing as below:
SHSE:600568'
s Days Payable Range Over the Past 10 Years
Min: 53.77 Med: 89.85 Max: 174.74
Current: 55.01
During the past 13 years, Zhongzhu Healthcare Holding Co's highest Days Payable was 174.74. The lowest was 53.77. And the median was 89.85.
SHSE:600568's Days Payable is ranked worse than 71.41% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SHSE:600568: 55.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhu Healthcare Holding Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhongzhu Healthcare Holding Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhongzhu Healthcare Holding Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Zhongzhu Healthcare Holding Co's Days Payable falls into.
Zhongzhu Healthcare Holding Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhongzhu Healthcare Holding Co (SHSE:600568) has a Days Payable of 66.17 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhongzhu Healthcare Holding Co and its competitors. This is 26% below median its historical median of 89.85. Over the past decade, Zhongzhu Healthcare Holding Co's Days Payable has ranged from 53.77 to 174.74. According to the industry distribution chart, Zhongzhu Healthcare Holding Co ranks #662 out of 927 companies in the Drug Manufacturers industry, placing it in the top 71.4%.
Is Zhongzhu Healthcare Holding Co's Days Payable too high?
Zhongzhu Healthcare Holding Co's current Days Payable of 66.17 is 26% below median its 10-year median of 89.85. Over the past 10 years, this metric has ranged from a low of 53.77 to a high of 174.74. The Drug Manufacturers industry median Days Payable is 90.38. Zhongzhu Healthcare Holding Co's value of 66.17 is 26.8% below this industry median. Based on the distribution chart, Zhongzhu Healthcare Holding Co ranks #662 out of 927 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Zhongzhu Healthcare Holding Co has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhongzhu Healthcare Holding Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Zhongzhu Healthcare Holding Co ranks #662 out of 927 companies for Days Payable. This places Zhongzhu Healthcare Holding Co in the lower half of its industry. The industry median Days Payable is 90.38. Zhongzhu Healthcare Holding Co's value of 66.17 is 26.8% below this benchmark. Historically, Zhongzhu Healthcare Holding Co's own Days Payable has ranged from 53.77 to 174.74 over the past decade. While the company's 10-year median is 89.85 vs. the industry median of 90.38, Zhongzhu Healthcare Holding Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhongzhu Healthcare Holding Co's current Days Payable of 66.17 is 26.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zhongzhu Healthcare Holding Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhongzhu Healthcare Holding Co's current Days Payable is 66.17, which is 26% below median its own 10-year median of 89.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongzhu Healthcare Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co (SHSE:600568) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥1.88, compared to a current price of ¥2.31 — trading 22.9% above its estimated fair value. The current Days Payable is 66.17, which is 26% below median its 10-year median of 89.85 and 26.8% below the Drug Manufacturers industry median of 90.38. Zhongzhu Healthcare Holding Co's overall GF Score™ is 54/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zhongzhu Healthcare Holding Co (SHSE:600568), the current Days Payable is 66.17 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhongzhu Healthcare Holding Co (SHSE:600568) Overvalued in 2026?
Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co stock appears to be overvalued.
The current stock price of ¥2.31 is trading 22.9% above its estimated GF Value™ of ¥1.88.
GuruFocus considers Zhongzhu Healthcare Holding Co to be Modestly Overvalued.
Key valuation signals for SHSE:600568:
Days Payable: 66.17 (26% below median its 10-year median of 89.85)
GF Value™: ¥1.88 vs. price of ¥2.31 (22.9% above fair value)
Industry Position: 26.8% below the Drug Manufacturers median (#662 of 927)
No single metric tells the full story. See the SHSE:600568 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhongzhu Healthcare Holding Co Business Description
Zhongzhu Healthcare Holding Co Ltd produces and sells ophthalmic, antiviral, and anti-infective drugs in China. Its products include eye and nasal drops, injections, solid preparations, and other products. The product consists of Pearl Eye Drops, Sodium Cromolyn Eye Drops, Acyclovir Eye Drops, Hydroxybenzazole Hydrochloride Eye Drops, Acyclovir Dispersible Tablets, Gatifloxacin Tablets.
54GF Score
Get the complete analysis for SHSE:600568
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600568 has been successfully added to your 
